Medexprim, Illuminate expand reach

By staff writers

November 29, 2021 -- French image archive software developer Medexprim and artificial intelligence (AI) software developer Illuminate are building upon their three-year partnership to support U.S. and European Union research studies.

The collaboration uses AI to improve translational medicine, with Illuminate focusing on the provider side and Medexprim focusing on real-world evidence, according to the firms.

Medexprim provides researchers with deidentified, aggregated, multicentric, curated, regulatory-grade datasets, while Illuminate helps hospitals unlock patient records stored across multiple systems to deliver actionable intelligence, the firms said.

Copyright © 2021
Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking